Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose Decitabine for Decreased Donor Chimerism After Allo-HSCT
NCT03663751Phase 2Completed
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Jul 2018
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of decitabine in hematologic malignancy, Graft failure, sponsored by Shanghai Jiao Tong University School of Medicine. Started Jul 2018; status: completed.
02
Drugs
decitabine
03
Conditions
hematologic malignancyGraft failure
Beyond the preview
Go deeper on NCT03663751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03663751.